MENU
IXHL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Incannex Healthcare (IXHL) Earnings Date & Reports
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions... Show more
A.I. Advisor
published Earnings
IXHL is expected to report earnings to rise 371.43% to -66 cents per share on November 13
Q3'26
Est.
$-0.66
Q2'26
Missed
by $0.27
Q1'26
Beat
by $70.74
Q4'25
Beat
by $67.98
Q2'25
Beat
by $67.62
The last earnings report on September 25 showed earnings per share of -14 cents, missing the estimate of 12 cents. With 36.99K shares outstanding, the current market capitalization sits at 28.10M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Industry
N/A
Address
8 Century Circuit Norwest
Phone
+61 409840786
Employees
12
Web
https://www.incannex.com.au